D&DIAGNOSIS & EARLY DETECTION
Diagnosis & Early Detection/November 14, 2026/3 min read

Living Well With Type 1 Diabetes: What's Changing in Care and Detection

New screening methods, immunotherapies, and technology are transforming how type 1 diabetes is detected and managed—offering earlier intervention and better tools to stay active and healthy.

Research summaryVideo report, corroborated with 3 indexed studies

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

diagnosisscreeningstaging

Key takeaways

  • Blood screening for autoantibodies can now identify type 1 diabetes earlier, before symptoms appear, allowing treatment to start sooner
  • Teplizumab, an FDA-approved immunotherapy, can delay the onset of clinical type 1 diabetes in high-risk individuals
  • Automated insulin delivery systems are becoming more sophisticated, making it easier to maintain healthy blood sugar levels during physical activity
  • New insulin types and improved glucose monitoring technology are helping reduce dangerous blood sugar swings
  • Type 1 diabetes is a hidden condition—many people living with it lead active, full lives without others knowing

Earlier Detection, Earlier Action

One of the most significant shifts in type 1 diabetes care is happening before diagnosis. Public health screening programs are now using blood tests to detect islet autoantibodies—markers that indicate the immune system is attacking insulin-producing cells. This allows doctors to identify people at risk long before symptoms develop.

The benefit is real: catching type 1 diabetes early means people can start disease-modifying treatments sooner, potentially reducing dangerous complications like diabetic ketoacidosis (DKA) and delaying the need for insulin therapy. Earlier detection also creates a window of opportunity to intervene before the pancreas loses most of its insulin-producing capacity.

New Treatments Targeting the Immune System

In 2022, the FDA approved teplizumab, marking a watershed moment in type 1 diabetes treatment. This immunotherapy works differently than insulin—instead of replacing what the body can't make, it modulates the immune system to slow or delay the autoimmune attack on insulin-producing cells.

It's important to understand what teplizumab does and doesn't do: it delays the onset of clinical type 1 diabetes in people at high risk, giving the pancreas more time to function. It is not a cure, and people who receive it will still need to be monitored closely. Researchers are also investigating other immune-based therapies aimed at preserving the pancreas's remaining insulin-producing capacity in people already diagnosed.

Technology Making Active Life Easier

For people managing type 1 diabetes day-to-day, automated insulin delivery (AID) systems—which combine continuous glucose monitors with insulin pumps—are becoming more refined. These systems adjust insulin delivery automatically, helping maintain healthier blood sugar levels with less manual work.

Physical activity and exercise are especially important for people with type 1 diabetes, but they can cause unpredictable blood sugar swings. New clinical guidelines from the European Association for the Study of Diabetes and International Society for Pediatric and Adolescent Diabetes now provide detailed strategies for using AID systems during exercise. Additionally, newer insulin formulations—ultrarapid, ultralong, and glucose-responsive types—are helping minimize blood sugar fluctuations.

A Hidden Condition, an Active Life

Type 1 diabetes is what many call a hidden condition. Someone could walk past you on the street, dance on a stage, or excel in sports without you knowing they have it. That invisibility can make the diagnosis feel isolating, but it also means that having type 1 diabetes doesn't have to define what people can do.

The advances in screening, immunotherapy, and technology are reshaping what it means to live with type 1 diabetes. While challenges remain—scaling new therapies to reach everyone who needs them, and managing blood sugar during varied daily activities—the trajectory is clear: earlier detection, more treatment options, and better tools for staying healthy and active.

Evidence label

Origin: YouTube / Are You Okay? (Video report). Evidence: Video report, corroborated with 3 indexed studies. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

From Type1Cure

Read more of our own writing in Stories

More evidence-labeled coverage across the Type1Cure library.